Gregory O. Anglum
Net Worth
Last updated:
What is Gregory O. Anglum net worth?
The estimated net worth of Mr. Gregory O. Anglum is at least $2,757,013 as of 14 Feb 2022. He owns shares worth $402,695 as insider, has earned $15,518 from insider trading and has received compensation worth at least $2,338,800 in Bioventus Inc..
What is the salary of Gregory O. Anglum?
Mr. Gregory O. Anglum salary is $584,700 per year as Senior Vice President, Chief Financial Officer & Principal Accounting Officer in Bioventus Inc..
How old is Gregory O. Anglum?
Mr. Gregory O. Anglum is 54 years old, born in 1971.
What stocks does Gregory O. Anglum currently own?
As insider, Mr. Gregory O. Anglum owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bioventus Inc. (BVS) | Senior Vice President, Chief Financial Officer & Principal Accounting Officer | 55,013 | $7.32 | $402,695 |
What does Bioventus Inc. do?
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Gregory O. Anglum insider trading
Bioventus Inc.
Mr. Gregory O. Anglum has made only one insider trade between 2021-2022, according to the Form 4 filled with the SEC.
As of 14 Feb 2022 he still owns at least 55,013 units of BVS stock.
Bioventus key executives
Bioventus Inc. executives and other stock owners filed with the SEC:
- Mr. Anthony D'Adamio (64) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Gregory O. Anglum (54) Senior Vice President, Chief Financial Officer & Principal Accounting Officer
- Mr. John Ernest Nosenzo (67) Senior Vice President & Chief Commercial Officer
- Mr. Kenneth M. Reali (59) Chief Executive Officer & Director
- Ms. Alessandraa Pavesio (58) Senior Vice President & Chief Science Officer